282 related articles for article (PubMed ID: 21145444)
1. Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients.
Fung SJ; Sivagnanasundaram S; Weickert CS
Biol Psychiatry; 2011 Jan; 69(1):71-9. PubMed ID: 21145444
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons.
Eastwood SL; Harrison PJ
Schizophr Res; 2005 Mar; 73(2-3):159-72. PubMed ID: 15653259
[TBL] [Abstract][Full Text] [Related]
3. Expression of VGluT1 and VGAT mRNAs in human dorsolateral prefrontal cortex during development and in schizophrenia.
Fung SJ; Webster MJ; Weickert CS
Brain Res; 2011 May; 1388():22-31. PubMed ID: 21396926
[TBL] [Abstract][Full Text] [Related]
4. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain.
Weickert CS; Straub RE; McClintock BW; Matsumoto M; Hashimoto R; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
Arch Gen Psychiatry; 2004 Jun; 61(6):544-55. PubMed ID: 15184234
[TBL] [Abstract][Full Text] [Related]
5. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.
Sawada K; Barr AM; Nakamura M; Arima K; Young CE; Dwork AJ; Falkai P; Phillips AG; Honer WG
Arch Gen Psychiatry; 2005 Mar; 62(3):263-72. PubMed ID: 15753239
[TBL] [Abstract][Full Text] [Related]
6. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.
Tang J; LeGros RP; Louneva N; Yeh L; Cohen JW; Hahn CG; Blake DJ; Arnold SE; Talbot K
Hum Mol Genet; 2009 Oct; 18(20):3851-63. PubMed ID: 19617633
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer's disease.
Ramos-Miguel A; Sawada K; Jones AA; Thornton AE; Barr AM; Leurgans SE; Schneider JA; Bennett DA; Honer WG
Acta Neuropathol; 2017 Mar; 133(3):395-407. PubMed ID: 27866231
[TBL] [Abstract][Full Text] [Related]
8. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia.
Talbot K; Eidem WL; Tinsley CL; Benson MA; Thompson EW; Smith RJ; Hahn CG; Siegel SJ; Trojanowski JQ; Gur RE; Blake DJ; Arnold SE
J Clin Invest; 2004 May; 113(9):1353-63. PubMed ID: 15124027
[TBL] [Abstract][Full Text] [Related]
9. Dysbindin-1 and schizophrenia: from genetics to neuropathology.
Owen MJ; Williams NM; O'Donovan MC
J Clin Invest; 2004 May; 113(9):1255-7. PubMed ID: 15124015
[TBL] [Abstract][Full Text] [Related]
10. Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia.
Rocco BR; Lewis DA; Fish KN
Biol Psychiatry; 2016 Jun; 79(12):1006-15. PubMed ID: 26364548
[TBL] [Abstract][Full Text] [Related]
11. Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder.
Eastwood SL; Harrison PJ
Biol Psychiatry; 2010 Jun; 67(11):1010-6. PubMed ID: 20079890
[TBL] [Abstract][Full Text] [Related]
12. Snapin is critical for presynaptic homeostatic plasticity.
Dickman DK; Tong A; Davis GW
J Neurosci; 2012 Jun; 32(25):8716-24. PubMed ID: 22723711
[TBL] [Abstract][Full Text] [Related]
13. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.
Weickert CS; Rothmond DA; Hyde TM; Kleinman JE; Straub RE
Schizophr Res; 2008 Jan; 98(1-3):105-10. PubMed ID: 17961984
[TBL] [Abstract][Full Text] [Related]
14. Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.
Jentsch JD; Trantham-Davidson H; Jairl C; Tinsley M; Cannon TD; Lavin A
Neuropsychopharmacology; 2009 Nov; 34(12):2601-8. PubMed ID: 19641486
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex: analysis of synaptogyrin, vesicle-associated membrane protein, and syntaxin.
Bragina L; Giovedì S; Barbaresi P; Benfenati F; Conti F
Neuroscience; 2010 Feb; 165(3):934-43. PubMed ID: 19909789
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1.
Yuan Q; Yang F; Xiao Y; Tan S; Husain N; Ren M; Hu Z; Martinowich K; Ng JS; Kim PJ; Han W; Nagata KI; Weinberger DR; Je HS
Biol Psychiatry; 2016 Aug; 80(4):312-322. PubMed ID: 26386481
[TBL] [Abstract][Full Text] [Related]
17. Prenatal ethanol exposure in rats decreases levels of complexin proteins in the frontal cortex.
Barr AM; Hofmann CE; Phillips AG; Weinberg J; Honer WG
Alcohol Clin Exp Res; 2005 Nov; 29(11):1915-20. PubMed ID: 16340446
[TBL] [Abstract][Full Text] [Related]
18. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
Kimoto S; Zaki MM; Bazmi HH; Lewis DA
JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
[TBL] [Abstract][Full Text] [Related]
19. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.
Numakawa T; Yagasaki Y; Ishimoto T; Okada T; Suzuki T; Iwata N; Ozaki N; Taguchi T; Tatsumi M; Kamijima K; Straub RE; Weinberger DR; Kunugi H; Hashimoto R
Hum Mol Genet; 2004 Nov; 13(21):2699-708. PubMed ID: 15345706
[TBL] [Abstract][Full Text] [Related]
20. Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development.
Halim ND; Weickert CS; McClintock BW; Hyde TM; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2003 Sep; 8(9):797-810. PubMed ID: 12931207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
